RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE

書誌詳細
主要な著者:	Seeman, E, Chapurlat, R, Cheung, A, Felsenberg, D, La-Roche, M, Reeve, J, Thomas, T, Zanchetta, J, Bock, O, Morris, E, Tile, L, D'Alo, G, Darbie, L, Borah, B, Rizzoli, R
フォーマット:	Journal article
出版事項:	2010

類似資料

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
著者:: Bala, Y, 等
出版事項: (2014)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
著者:: Stefano Palomba, 等
出版事項: (2010-06-01)

Risedronate or exercise for lean mass preservation during menopause: secondary analysis of a randomized controlled trial
著者:: Laura E. Flores, 等
出版事項: (2022-07-01)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
著者:: Seeman, A, 等
出版事項: (2000)

Risedronate-loaded aerogel scaffolds for bone regeneration
著者:: Nahla El-Wakil, 等
出版事項: (2023-12-01)

Once-monthly risedronate for postmenopausal osteoporosis
著者:: Kristina Casadei, 等
出版事項: (2009-02-01)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
著者:: Raja Bobba, 等
出版事項: (2007-10-01)

Reversal deterioration of renal function accompanied with primary hypothyrodism
著者:: Dragović Tamara
出版事項: (2012-01-01)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
著者:: Duncan, E, 等
出版事項: (2005)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
著者:: Ma. Florencia Peralta, 等
出版事項: (2021-05-01)

Effect of risedronate on bone loss at discontinuation of denosumab
著者:: Michel Laroche, 等
出版事項: (2020-12-01)

Risedronate inhibits human osteosarcoma cell invasion
著者:: Jung Sung, 等
出版事項: (2009-07-01)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
著者:: Eliska Vaculikova, 等
出版事項: (2014-11-01)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
著者:: Diane Kleinermans, 等
出版事項: (2022-06-01)

The Potential of Bisphosphonate Risedronate Hydrogel in Preventing Relapse Movement
著者:: Utari, Tita Ratya, 等
出版事項: (2022)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
著者:: Abdurrahman Yeter, 等
出版事項: (2014-12-01)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
著者:: Roelofs, A, 等
出版事項: (2005)

The Effect of Menopause on Antipsychotic Response
著者:: Alexandre González-Rodríguez, 等
出版事項: (2022-10-01)

Spectrophotometric Determination of Risedronate Sodium in Pharmaceutical Preparations by Derivative and Continuous Wavelet Transforms
著者:: Uğurlu, G., 等
出版事項: (2008-12-01)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
著者:: Kashemirov, B, 等
出版事項: (2008)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
著者:: Yohei Asada, 等
出版事項: (2019-01-01)

The Effects of Risedronate Treatment on the Pain and the Quality of Life - Original Investigation
著者:: Evrim Karadağ Saygı, 等
出版事項: (2009-08-01)

Development of Risedronate-Loaded Nano Capsules for Calvaria Healing in Rabbit
著者:: Hesam Aldin Hoseinzadeh, 等
出版事項: (2019-04-01)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
著者:: María J Moro-Álvarez, 等
出版事項: (2008-06-01)

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.
著者:: Sorensen, O, 等
出版事項: (2003)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
著者:: Marma, MS, 等
出版事項: (2007)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
著者:: Coxon, F, 等
出版事項: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
著者:: Coxon, F, 等
出版事項: (2008)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
著者:: Tahir Masud, 等
出版事項: (2009-11-01)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
著者:: Shabnam Aghayan, 等
出版事項: (2021-03-01)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
著者:: Vincenzo Monda, 等
出版事項: (2017-09-01)

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
著者:: Amy L. Inselman, 等
出版事項: (2024-04-01)

Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
著者:: Sugiyama, T, 等
出版事項: (2011)

Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration
著者:: Tomasz Miazgowski, 等
出版事項: (2012-01-01)

The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
著者:: Alexandre González-Rodríguez, 等
出版事項: (2019-07-01)

Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors
著者:: Kolmas J, 等
出版事項: (2017-08-01)

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis
著者:: Brounais-Le Royer, B, 等
出版事項: (2012)

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
著者:: Cooper, C, 等
出版事項: (2001)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
著者:: Kavanagh, K, 等
出版事項: (2006)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
著者:: Mabilleau, G, 等
出版事項: (2011)